Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

Overview

Información sobre este estudio

The aim of this study is to evaluate the potential improvement in colonoscopy procedure outcomes when using the Pure-Vu System in hospitalized patients who are indicated for colonoscopy procedure.

 

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Hospitalized patients who are indicated for a screening, diagnostic, surveillance or therapeutic colonoscopy.
  • Patients' age > 22 years.
  • Patient has signed the informed consent.

Exclusion Criteria:

  • Patients with known Inflammatory Bowel Disease and / or active Colitis.
  • Patients with active diverticulitis.
  • Patients with known or detected (during colonoscopy) bowel obstruction.
  • Patients with BMI ≤ 18 .
  • Patients with ascites Child Pugh C.
  • Patients who are 30 days post-transplant.
  • Patients treated with Peritoneal dialysis.
  • Patients under active IV inotropic medications.
  • Patients with LVAD.
  • Patients who have active anticoagulant medications (excluding aspirin) or dual antiplatelet therapy in their system prior to the procedure. (Note: to avoid exclusion therapy should be discontinued 48 hours or greater prior to the procedure based on discretion of physician).
  • Subjects with known coagulation disorder (INR ≥ 2 or platelets <50,000).
  • Subjects with hemodynamic instability.
  • Pregnancy (as stated by patient) or breast feeding.
  • Subjects with altered mental status/inability to provide informed consenPatients who have participated in another interventional clinical study in the last 2 months.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Bhaumik Brahmbhatt, M.B.B.S.

Cerrado para la inscripción

Rochester, Minn.

Investigador principal de Mayo Clinic

Bhaumik Brahmbhatt, M.B.B.S.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20435272

Mayo Clinic Footer